Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drew Weissman

Showing results (41-50 of 293) with videos related to

Pageof 30
Sort By:
Advanced Drug Delivery Reviews|February 11, 2024
Emerging strategies for nanomedicine in autoimmunityAjay S Thatte, Margaret M Billingsley, Drew Weissman, et al.
Journal of Virology|June 26, 2009
gp340 promotes transcytosis of human immunodeficiency virus type 1 in genital tract-derived cell lines and primary endocervical tissueEarl Stoddard, Houping Ni, Georgetta Cannon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2007
gp340 expressed on human genital epithelia binds HIV-1 envelope protein and facilitates viral transmissionEarl Stoddard, Georgetta Cannon, Houping Ni, et al.
Open Forum Infectious Diseases|May 8, 2018
Common Variation in <i>NLRP3</i> Is Associated With Early Death and Elevated Inflammasome Biomarkers Among Advanced HIV/TB Co-infected Patients in BotswanaShruthi Ravimohan, Kebatshabile Nfanyana, Neo Tamuhla, et al.
Nucleic Acids Research|August 5, 2011
Nucleoside modifications in RNA limit activation of 2'-5'-oligoadenylate synthetase and increase resistance to cleavage by RNase LBart R Anderson, Hiromi Muramatsu, Babal K Jha, et al.
The Journal of Biological Chemistry|October 18, 2001
Reduced cell surface expression of CCR5 in CCR5Delta 32 heterozygotes is mediated by gene dosage, rather than by receptor sequestrationSundararajan Venkatesan, Ana Petrovic, Donald I Van Ryk, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 23, 2004
Cutting edge: innate immune system discriminates between RNA containing bacterial versus eukaryotic structural features that prime for high-level IL-12 secretion by dendritic cellsGary K Koski, Katalin Karikó, Shuwen Xu, et al.
Nature Reviews. Drug Discovery|July 1, 2024
Enhancing in situ cancer vaccines using delivery technologiesNingqiang Gong, Mohamad-Gabriel Alameh, Rakan El-Mayta, et al.
The Journal of Biological Chemistry|February 1, 2002
Extracellular mRNA induces dendritic cell activation by stimulating tumor necrosis factor-alpha secretion and signaling through a nucleotide receptorHouping Ni, John Capodici, Georgetta Cannon, et al.
Journal of Virology|September 5, 2025
Hepatitis C virus modified <sub>S</sub>E2<sub>F442NYT</sub>-mRNA-LNP candidate vaccine promotes helper CXCR5<sup>+</sup>T cellsYuki Haga, Preedia Babu E, Marzena Swiderska-Syn, et al.
Pageof 30

Showing results (41-50 of 293) with videos related to

Sort By:
Pageof 30
Advanced Drug Delivery Reviews|February 11, 2024
Emerging strategies for nanomedicine in autoimmunityAjay S Thatte, Margaret M Billingsley, Drew Weissman, et al.
Journal of Virology|June 26, 2009
gp340 promotes transcytosis of human immunodeficiency virus type 1 in genital tract-derived cell lines and primary endocervical tissueEarl Stoddard, Houping Ni, Georgetta Cannon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2007
gp340 expressed on human genital epithelia binds HIV-1 envelope protein and facilitates viral transmissionEarl Stoddard, Georgetta Cannon, Houping Ni, et al.
Open Forum Infectious Diseases|May 8, 2018
Common Variation in <i>NLRP3</i> Is Associated With Early Death and Elevated Inflammasome Biomarkers Among Advanced HIV/TB Co-infected Patients in BotswanaShruthi Ravimohan, Kebatshabile Nfanyana, Neo Tamuhla, et al.
Nucleic Acids Research|August 5, 2011
Nucleoside modifications in RNA limit activation of 2'-5'-oligoadenylate synthetase and increase resistance to cleavage by RNase LBart R Anderson, Hiromi Muramatsu, Babal K Jha, et al.
The Journal of Biological Chemistry|October 18, 2001
Reduced cell surface expression of CCR5 in CCR5Delta 32 heterozygotes is mediated by gene dosage, rather than by receptor sequestrationSundararajan Venkatesan, Ana Petrovic, Donald I Van Ryk, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 23, 2004
Cutting edge: innate immune system discriminates between RNA containing bacterial versus eukaryotic structural features that prime for high-level IL-12 secretion by dendritic cellsGary K Koski, Katalin Karikó, Shuwen Xu, et al.
Nature Reviews. Drug Discovery|July 1, 2024
Enhancing in situ cancer vaccines using delivery technologiesNingqiang Gong, Mohamad-Gabriel Alameh, Rakan El-Mayta, et al.
The Journal of Biological Chemistry|February 1, 2002
Extracellular mRNA induces dendritic cell activation by stimulating tumor necrosis factor-alpha secretion and signaling through a nucleotide receptorHouping Ni, John Capodici, Georgetta Cannon, et al.
Journal of Virology|September 5, 2025
Hepatitis C virus modified <sub>S</sub>E2<sub>F442NYT</sub>-mRNA-LNP candidate vaccine promotes helper CXCR5<sup>+</sup>T cellsYuki Haga, Preedia Babu E, Marzena Swiderska-Syn, et al.
Pageof 30